Work

Impact of p16 status on the results of the phase III cetuximab (cet)/radiotherapy (RT).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.6001

Authors: David Ira Rosenthal, Paul M. Harari, Jordi Giralt, Diana Bell, David Raben, Joyce Liu, Jeltje Schulten, K. Kian Ang, James A. Bonner

Institutions: The University of Texas MD Anderson Cancer Center, University of Wisconsin–Madison, Vall d'Hebron Hospital Universitari, University of Colorado Denver, Merck KGaA, Darmstadt (Germany), University of Alabama at Birmingham

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1888629366

Cites:

Cited by: 41

Related to: 10